Diageo resets expectations but offers plenty of self-help for the patient

Diageo is implementing a strategic reset, dubbed 'Accelerate', targeting $500 million in cost savings over three years to address stalled growth, margin compression, and elevated debt levels. Despite a forecast of only 1.9% organic revenue growth next year and a 1% decline in US spirits, analysts at UBS and Jefferies maintain 'buy' ratings, citing Diageo's defensive qualities and potential for a gradual re-rating driven by cost discipline, cash generation, and strategic disposals; focus areas include growing Guinness sales and reducing net debt to EBITDA from 3.4x to a targeted 3.1x by next year.

Analysis

Diageo is navigating a challenging period characterized by stalled growth, margin compression, and net debt to EBITDA standing at 3.4 times, which is above its desired level. In response, the company has initiated a strategic reset, termed 'Accelerate,' targeting $500 million in cost savings over three years across advertising, trade spend, overheads, and supply chain, with a significant portion intended to bolster margins. Despite forecasting a modest 1.9% organic revenue growth for the next fiscal year and an anticipated 1% decline in its profitable US spirits market—a segment broadly affected by US consumers spending 22% more for 8% fewer items over four years—management is focusing on controllable levers. This strategy includes a commitment to achieving $3 billion in annual free cash flow by 2026 and considering up to $3 billion in non-core brand divestments, which UBS estimates could reduce leverage by approximately 0.33x with minimal earnings impact, aiming for a net debt to EBITDA ratio of 3.1x by next year.

Analysts at UBS and Jefferies have reaffirmed 'buy' ratings, drawing parallels to Diageo's 2015 recovery driven by similar focuses on free cash flow, cost discipline, and capital returns. A significant growth driver is Guinness, which has demonstrated mid-teens sales growth for four consecutive years and now constitutes 10% of group revenue, with further expansion potential noted in the US and continental Europe. The stock currently trades at 16 times forecast 2026 earnings, a discount to the European staples sector average of around 18 times. Both UBS and Jefferies project a 15-20% upside, with respective price targets of 2,500p and 2,650p. While immediate high growth is not anticipated, the emphasis on cost efficiencies, cash generation, and strategic capital deployment is expected to support a gradual re-rating, contingent on the successful execution of the Accelerate program and an eventual recovery in market volumes.

Key Decisions for Investors

• Investors should acknowledge the medium-term nature of Diageo's recovery, as the 'Accelerate' program and market stabilization, particularly in US spirits, will require time to materialize.
• Monitor progress on the $500 million cost-saving initiative, the targeted $3 billion annual free cash flow by 2026, and any non-core asset disposals as key indicators of the strategy's effectiveness.
• Consider the current valuation discount relative to peers and analyst price targets as a potential opportunity for patient investors, contingent on management's ability to deliver on its deleveraging and margin improvement plans.
• Watch for continued strong performance from Guinness and early signs of stabilization in the US spirits market as potential catalysts for an improved outlook.